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Objective. To test the effectiveness of a colorectal cancer (CRC) screening intervention directed at three levels
(clinic, provider, patient) in a primary care setting.
Method.Weconducted a group randomized trial (Clinical Trials registration no. NCT01568151) among 10 pri-
mary care clinics in Columbus, Ohio that were randomized to a study condition (intervention or usual care). We
determined the effect of a multi-level, stepped behavioral intervention on receipt of a CRC screening test among
average-risk patients from these clinics over the study period.
Results. Patients (n = 527) who were outside of CRC screening recommendations were recruited. Overall,
35.4% of participants in the intervention clinics had received CRC screening by the end of the study compared
to 35.1% of participants who were in the usual care clinics. Time to CRC screening was also similar across arms
(HR = 0.97, 95% CI = 0.65–1.45).
Conclusion. The multi-level intervention was not effective in increasing CRC screening among participants
who needed a test, perhaps due to low participation of patients in the stepped intervention. Future studies uti-
lizing evidence-based strategies to encourage CRC screening are needed.© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Recent national data indicate that only 65% of United States (U.S.)
residents are within the recommended colorectal cancer (CRC) screen-
ing guidelines (Steele et al., 2013). Current guidelines by the U.S.
Preventive Services Task Force (USPSTF) recommend adults ages 50–
75 complete either an annual fecal occult blood test (FOBT), a ﬂexibleal Cancer Institute Grants: R01
omprehensive Cancer Center
choen is supported by a grant
5, Columbus, OH 43201, USA.
choen),
.edu (M.L. Pennell),
(M.L. Katz),
du (C.M. Tatum),
. This is an open access article undersigmoidoscopy every ﬁve years combined with FOBT every three
years, or a colonoscopy every 10 years (Levin et al., 2008).
CRC screening barriers are complex and occur at the patient, provid-
er, and system levels. Interventions aimed at one level have resulted in
limited improvement in CRC screening (Ferreira et al., 2005; Hoffman
et al., 2011; Katz et al., 2012). Interventions that target multiple levels
may be more effective since individuals respond differently to various
intervention strategies. Further, it may be ideal to implement interven-
tions that introduce increasingly intensive components to less motivat-
ed individuals over time, as opposed to intervention components with
equal intensity that are delivered once to all participants. However,
few studies have tested this approach (Christy et al., 2013; Fleisher
et al., 2012; Holden et al., 2010).
The study goal was to test the effectiveness of a stepped CRC screen-
ing intervention directed at three levels (clinic, provider, patient) in a
primary care setting. In addition, we conducted a process evaluation
to provide information that may be useful for designing future CRC
screening interventions.the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Study design
The study employed a group randomized trial design.Medical clinics
were randomized to conditions (intervention or control), and individual
patients and providers from each clinic were followed over time to as-
sess the effect of the multi-level intervention. Study details (including
sample size and power calculations) have been previously published
(Murray et al., 2013); however, we brieﬂy provide details below.
Clinics
Patients and physicians from 10 primary care clinics at the Ohio
State University Primary Care Network participated in the study. The
10 clinics had access to CRC screening modalities and referred patients
for screening to gastroenterology. A CONSORT diagram (Fig. 1) outlines
the number of participating clinics by study arm and patients recruited
and followed throughout the study. Units of assignment were clinics
and units of observation were eligible patients receiving care at those
clinics, with stratiﬁed randomassignment of clinics to each study condi-
tion (Murray et al., 2013).
Providers
To be eligible for participation, clinicians had to be an attending phy-
sician or resident at one of the 10 participating clinics. Potential physi-
cian participants were recruited via an email message from the study
principal investigator.
Patients
To be eligible for participation, patients had to: 1) be age ≥50;
2) have no prior history of familial/hereditary cancer syndrome, polyps,
or inﬂammatory bowel disease; 3) have current contact information;Fig. 1. CONSOR4) have two or more clinic visits in the past two years; 5) be at average
risk for CRC; 6) be in good health; and 7) be outside CRC screening
guidelines.
Once patientswere determined to be eligible based uponmedical re-
cord review (MRR), an email was sent to their physician asking permis-
sion to contact the patient. After receiving permission, the patient was
called by a research assistant. During the phone call, the study was de-
scribed; questions were answered; informed consent, HIPAA consent,
and a medical release were obtained; and the baseline survey was
administered. An exit survey was administered at approximately
24 months from baseline which included the same baseline measures
and questions to assess process evaluation measures. Participants
received a $20 grocery store gift card after completing each survey.
Informed consent procedures and the study protocol were approved
by the Institutional Review Board of Ohio State University and is regis-
tered on clinicaltrials.gov (NCT01568151).
Intervention
The multi-level intervention was directed at primary care practices
and targeted the clinic, providers, and average-risk patients age 50
and older. The intervention components were based on formative data
from focus groups, previous investigator experience, and previous liter-
ature (Katz et al., 2007; Paskett et al., 2006; Post et al., 2008). The theo-
retical framework for the clinic-directed intervention was the Chronic
Care Model (Wagner et al., 2005). The patient- and provider-directed
interventions were based on health behavior theories, including the
Health Belief Model (Rosenstock, 1974), the Transtheoretical Model
(Prochaska and Velicer, 1997), and social support (Heaney and Israel,
2002) using lay health advisors (LHAs).
Clinics
The ﬁrst phase of the intervention focused on the clinic and
healthcare providers. It began after the eligible patients were recruited,T diagram.
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vention focused on self-management support for CRC screening by
having waiting room and examination room posters and brochures for
the patients. In the waiting rooms, copies of educational materials
(from the National Cancer Institute and American Cancer Society)
were available to patients. Informational posters about CRC and CRC
screening were displayed in prominent locations in the clinics. In
addition, posters that encouraged patient communication with their
physician about CRC screening were placed in exam rooms.
Providers
The educational session for the physicians, facilitated by a member
of the research team, included a PowerPoint presentation and handouts
on current CRC screening literature. The 1-hour presentation focused on
current evidence-based CRC screening guidelines and on communica-
tion strategies designed to assist physicians in discussing CRC screening
with patients. The communication strategies were modiﬁed from an
evidence-based tobacco cessation program (Fiore et al., 2008).
Physicians were asked complete surveys that assessed CRC screening
knowledge and attitudes before and after the educational session.
Patients
After the clinic- and provider-level interventionswere implemented
and completed, a second MRR identiﬁed participating patients who
were still not within CRC screening guidelines. The patient-level inter-
vention then targeted those participants and was conducted in three
increasingly intensive steps. The ﬁrst step was a personalized letter
sent to the participants from their primary care physician telling the
patient to get a CRC test. The mailing also included CRC screening bro-
chures from the American Cancer Society about general screening infor-
mation and a CRC screening study-speciﬁc ﬂyerwith a photo of an adult
similar to the participant's gender and race and the local clinic nameand
phone number. Three months after the letter and brochures were sent,
another MRR determined if the participant completed a CRC screening
test. If individuals had not completed screening at that time, they
progressed to the second step of the patient-level intervention.
The second step involved a barriers counseling telephone call con-
ducted by a LHA. The three LHAs were women from the Columbus,
Ohio area, aged 40–50, not patients from participating clinics, and had
no medical training. LHAs received education about CRC, screening
tests, andwere given the opportunity to observe a video of a colonosco-
py. LHA training consisted of a review of the CRC barriers assessment
and telephone counseling scripts, assessment techniques, role playing,
and practice counseling sessions. On the call, the LHA assessed barriers
to CRC screening and offered counseling to eliminate any reported
barriers.
If a participant had not completed a CRC screening test within three
months after the barriers counseling call (as determined by MRR), they
were contacted for a one-on-one, in-person visit with the LHA, the third
step of the patient-level intervention. The in-person visit, held at a loca-
tion chosen by the participant (e.g., home, library), used a structured
presentation that included: 1) information about the importance of
completing a CRC screening test; 2) CRC screening test options;
3) how to discuss CRC screening with providers; 4) CRC screening bar-
riers; and 5) tips to prevent CRC. The goalwas to assess the participant's
knowledge about CRC screening, answer questions about screening,
address barriers, andprovide encouragement and support for screening.
Study timeline
Clinic and physician recruitment began in January 2007 and ﬁnished
in April 2008. Patient recruitment began in January 2009 and ﬁnished in
August 2010. The clinic- and provider-level interventions began in
January 2011. The provider-level intervention ﬁnished in December2011. At the completion of the provider-level intervention, the
patient-level intervention began in January 2012 and ﬁnished in
December 2012. The clinic-level intervention continued during the
patient-level intervention and ﬁnished in December 2012. The patient
exit surveys and ﬁnal MRR were completed by August 2013.Measures
Outcome variable: CRC screening behavior
The primary outcome was whether the participants from the inter-
vention and control clinics completed any CRC screening test (FOBT,
ﬂexible sigmoidoscopy, or colonoscopy) by the end of the study as
determined by MRR.Independent variables
Patient demographic characteristics
Participants provided information about their age, gender, race,
ethnicity, marital status, education, household income, employment
status, health insurance, and smoking status at baseline.Patient healthcare
Participants were asked about their comorbidities (“do have any
medical condition(s) that require you to go to a doctor on a regular
basis? If yes, what is the condition(s)?”), past CRC screening history
(“have you ever had a FOBT, sigmoidoscopy, or colonoscopy? If yes,
when?”), regular source of medical care (clinic name), and most recent
CRC test (where it was obtained and results). On the exit survey, partic-
ipants were asked if they were still a patient at the clinic where they
reported receiving care at the beginning of the study.Patient CRC screening knowledge
Patient CRC screening knowledge was measured by 10 true or false
statements about CRC screening (i.e., CRC screening age, susceptibility)
(McAlearney et al., 2008). Responses were summed, creating knowl-
edge scores (0–10) with higher scores representing more statements
being answered correctly.Patient beliefs regarding CRC screening
To assess CRC screening beliefs, participants were asked about the
importance of CRC screening (e.g., “I think colon cancer screening
tests are useful in ﬁnding colon cancer early”) and potential barriers
(e.g., “I amafraid that a screening testwill ﬁnd colon cancer”) associated
with screening. Participant beliefs were measured by a 5-item scale
scored on a 5-point Likert scale ranging from “strongly agree” to
“strongly disagree”. Responses were summed, creating belief scores
(5–25) with higher scores representing more positive CRC screening
beliefs.Patient intention to screen
Participants were asked (yes/no) if they: were willing to have a CRC
screening test, have thought about talking to their doctor about com-
pleting a CRC screening test in the next 6months, intended to complete
a CRC screening test in the next 6 months, took any actions based on
provided CRC information, and made an appointment to get a CRC
screening test.
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Participants were asked (yes/no) if their doctor: asked about their
family history of CRC and changes in bowel habits, provided information
about CRC screening, and recommended a CRC screening test.Physician CRC screening knowledge
To determine knowledge about CRC screening, physicians were
asked about state and national CRC incidence and mortality rates,
patient-level predictors of CRC screening, and theUSPSTF recommenda-
tions. Example items include, “Themost important factor for getting pa-
tients to complete CRC screening is a recommendation from their
healthcare provider” and “CRC incidence and mortality rates are higher
in Ohio compared to U.S. rates.” Physician knowledge was measured by
5 true/false statements with correct answers representing higher levels
of knowledge.Process evaluation
Process evaluation was conducted during the clinic-, provider-, and
each step of the patient-level intervention. Process evaluation of the
clinic-level intervention involved conﬁrmation each month that CRC
screening posters and brochures were visible in the waiting and exam-
ination rooms of the intervention clinics. For the provider-level process
evaluation, attendance at the educational session and response rates of
the pre-and post-survey were assessed. For the patient-level interven-
tion, the number of participants who completed each step of the
patient-level intervention and were exposed to the clinic-level inter-
vention was assessed.Statistical analyses
The primary outcome was receipt of a CRC screening test (FOBT,
ﬂexible sigmoidoscopy, or colonoscopy) at any point during the study
period (as determined by MRR). From the 531 patients consented,
three patients reported having had a colonoscopy but refused MRR
and were eliminated from analyses. A logistic mixed model was used
to test for differences in screening at the end of the study between
study arms (n = 522 due to 6 patients missing demographic informa-
tion). The model contained a random clinic effect to account for
the clinic-level randomization and ﬁxed effects of study arm and
any demographic factors that were not evenly distributed between
study arms at baseline. ANCOVA models for clinic rates or means
weighed by the number of participants in each clinic at exit were used
to explore the effect of the intervention on whether the participant re-
ported his/her doctor requested a CRC screening test, if the doctor
asked about family history of CRC and changes in bowel habits, partici-
pant CRC screening knowledge score, and participant CRC screening
beliefs score.
A Cox regression model with a shared gamma frailty (accounting
for clinic effect) was used to compare time to CRC screening across
arms. An exploratory analysis was performed to determine if age, in-
surance, race, income, education, gender, and marital status modi-
ﬁed the intervention effect. Predictors of receiving CRC screening
were also examined. A backwards selection process was used to
build a multivariable prediction model, initially including all vari-
ables signiﬁcant at the 0.1 level, univariately. Patients with missing
data on the set of predictors under consideration were excluded
from analyses, leaving 483 for these analyses. The logistic mixed
model was ﬁt using SAS v9.3 PROC GLIMMIX (SAS Institute, Cary,
NC), and the shared frailty model was ﬁt using Intercooled Stata 11
(Stata Corp, College Station, TX).Results
Patient participants
The demographic characteristics of participants in the intervention
and control clinics (n = 531) are presented in Table 1. The majority of
the participants were female (58.4%), white (65.3%), college graduates
(39.3%), and married (47.7%) with an average age of 56 years. A greater
percentage of participants in the control clinics reported having a
chronic medical condition (70% versus 54%). All other demographic
factors were similar across arms.Patient-level primary outcome
A total of 98 (35.4%) of the 277 participants from the interven-
tion clinics completed CRC screening during the study compared
to 88 (35.1%) of the 251 participants from the control clinics. The
odds ratio comparing the CRC screening rate among intervention
versus control participants, controlling for clinic and presence of a
chronic medical condition was 0.98 (95% CI = 0.52, 1.85), indicating
no difference by study arm. Time to CRC screening was also similar
across study arms according to the shared frailty model (HR= 0.97,
95% CI = 0.65–1.45) (Fig. 2). None of the demographic factors sig-
niﬁcantly modiﬁed the effect of the intervention on the proportion
of participants within CRC screening guidelines or time to CRC
screening. In a sensitivity analysis, the rate of screening among partici-
pants who were still patients of the study clinic at their exit interview
(n = 189), 107 (56.6%) completed CRC screening and the screening
rate was similar across study arms (54% control versus 59% intervention,
p = 0.57).Patient-level secondary outcomes
Reported barriers
At the second step of the intervention (phone call), the most com-
mon self-reported barriers to CRC screening (n = 109) were: lack of
personal and family risk (32.1%), screening was not a priority (22.9%),
and other priorities/issues (health, family related) (17.4%). At Step 3 of
the intervention (in-person visit), the most commonly self-reported
barriers to CRC screening (n = 64) were: lack of personal and family
risk (20.3%), no insurance (17.2%), and misconceptions/fear about the
test (15.6%).Intention to screen, knowledge, and beliefs
Participants' intention to be screened was only asked of those who
were outside of guidelines by MRR and self-report, thus, among the
144 who were outside of CRC screening guidelines and completed an
exit survey, 60 (41.7%) reported intention to receive CRC screening.
The odds ratio for intention to screen for the participants from the in-
tervention clinics versus the control clinics was not signiﬁcant (OR =
1.52; 95% CI = 0.60–3.83). Of the 85 intervention and 67 control
arm participants who reported actions based on CRC information
they received, 69 (81.2%) intervention and 51 (76.1%) control arm par-
ticipants reported having made an appointment to get a CRC screening
test.
The effect of the intervention on knowledgewas not signiﬁcantwith
a mean increase in the participants from intervention clinics of 0.46 as
compared to 0.51 in the participants from the control clinics (p =
0.83). Similarly, no signiﬁcant effectwas observed for the CRC screening
beliefs score with a mean increase of 0.71 for the participants from in-
tervention clinics and 0.49 for the participants from control clinics
(p = 0.41).
Table 1
Participants characteristics by study arm (n = 531).a
Variable Level Control
(n = 251)
n(%)
Intervention
(n = 280)
n(%)
Total
(n = 531)
n(%)
Age (mean ± SD) 56.1 ± 6.8 56.2 ± 6.6 56.1 ± 6.7
Gender Male 106 (42.2) 115 (41.1) 221 (41.6)
Female 145 (57.8) 165 (58.9) 310 (58.4)
Race White 164 (66.1) 181 (64.6) 345 (65.3)
Black 70 (28.2) 83 (29.6) 153 (29.0)
Other 14 (5.6) 16 (5.7) 30 (5.7)
Hispanic ethnicity No 246 (98.8) 272 (97.8) 518 (98.3)
Yes 3 (1.2) 6 (2.2) 9 (1.7)
Marital status Married/living as married 123 (49.2) 130 (46.4) 253 (47.7)
Divorced/separated/widowed 89 (35.6) 94 (33.6) 183 (34.5)
Single/never married 38 (15.2) 56 (20.0) 94 (17.7)
Education level High school or less 59 (23.6) 54 (19.4) 113 (21.4)
Some college/associate's degree 91 (36.4) 117 (41.9) 208 (39.3)
College graduate/graduate school 100 (40.0) 108 (38.7) 208 (39.3)
Annual household income in last year Less than $30K 86 (36.3) 98 (36.7) 184 (36.5)
$30K–$69,999 71 (30.0) 95 (35.6) 166 (32.9)
$70K+ 80 (33.8) 74 (27.7) 154 (30.6)
Employment status Full/part time 138 (55.2) 176 (62.9) 314 (59.2)
Retired/volunteer 42 (16.8) 42 (15.0) 84 (15.8)
Disabled/unemployed 70 (28.0) 62 (22.1) 132 (24.9)
Insurance Uninsured 36 (14.9) 40 (14.3) 76 (14.6)
Public 64 (26.4) 68 (24.4) 132 (25.3)
Private 142 (58.7) 171 (61.3) 313 (60.1)
Smoking status Current 85 (34.0) 70 (25.3) 155 (29.4)
Former 60 (24.0) 77 (27.8) 137 (26.0)
Never 105 (42.0) 130 (46.9) 235 (44.6)
Health compared to others same age Excellent 31 (12.5) 57 (20.4) 88 (16.7)
Very good 81 (32.7) 104 (37.1) 185 (35.0)
Good 81 (32.7) 80 (28.6) 161 (30.5)
Fair 46 (18.5) 32 (11.4) 78 (14.8)
Poor 9 (3.6) 7 (2.5) 16 (3.0)
Any chronic medical conditions No 74 (29.8) 128 (46.2) 202 (38.5)
Yes 174 (70.2) 149 (53.8) 323 (61.5)
Have you ever done a stool blood test using a home test kit No 212 (84.5%) 237 (84.6%) 449 (84.6%)
Yes 39 (15.5%) 43 (15.4%) 82 (15.4%)
Have you ever done a stool blood test using a home test kit? No 233 (92.8%) 253 (90.4%) 486 (91.5%)
Yes 18 (7.2%) 27 (9.6%) 45 (8.5%)
Have you ever had a colonoscopy? No 238 (94.8%) 269 (96.1%) 507 (95.5%)
Yes 13 (5.2%) 11 (3.9%) 24 (4.5%)
Has your doctor ever asked you to have a FOBT, ﬂexible sigmoidoscopy,
or colonoscopy?
No 122 (48.6%) 125 (44.6%) 247 (46.5%)
Yes 129 (51.4%) 155 (55.4%) 284 (53.5%)
Would you be willing to have a colon cancer screening test if it were
recommended by your doctor?
No 58 (23.3%) 61 (21.9%) 119 (22.5%)
Yes 191 (76.7%) 218 (78.1%) 409 (77.5%)
Do you intend to complete a colon cancer screening test in the next 6 months? No 165 (66.0%) 168 (60.4%) 333 (63.1%)
Yes 85 (34.0%) 110 (39.6%) 195 (36.9%)
Since [baseline survey date] have you heard/seen/read anything about CRC? No 46 (29.9%) 56 (31.8%) 102 (30.9%)
Yes 108 (70.1%) 120 (68.2%) 228 (69.1%)
Are you currently still a patient at [baseline clinic]? No 58 (37.7%) 83 (47.2%) 141 (42.7%)
Yes 96 (62.3%) 93 (52.8%) 189 (57.3%)
a Descriptive analyses were conducted for the initial study sample.
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Of the 330 participants who completed the exit survey, 143 (81.3%)
intervention and 125 (81.2%) control arm participants reported that
their doctor asked them about their family history of CRC (p =
0.99). Similarly, 132 (75.0%) intervention and 109 (70.8%) control
arm participants reported their doctor asked about changes in their
bowel habits (p = 0.13). A similar proportion of intervention (68.2%)
and control (70.1%) arm participants reported that they received informa-
tion about CRC screening from their doctor (p= 0.53). Lastly, 150 (85.2%)
intervention and 133 (86.4%) control arm participants reported that their
doctor had recommended a CRC screening test (p = 0.28).Predictors of screening
In the multivariable model, employment status, smoking status,
screening beliefs, having completed an FOBT in the past, and thinkingof talking to a doctor about completing a CRC test were statistically
signiﬁcant predictors of getting CRC screening (Table 2). Retired and
disabled/unemployed participants had lower odds of having a CRC
screening test compared to participants with full- or part-time employ-
ment. Participants who had completed a FOBT in the past had higher
odds of being within CRC screening guidelines at the end of the study.
Participants who never smoked were more likely to have a CRC screen-
ing test compared to current and former smokers. Participants who
thought about talking to their doctor about a test in the next six months
and had a more positive belief score regarding CRC screening were also
more likely to have a CRC screening test (Table 3).
Provider-level outcomes
Therewas an increase from pre- to post-intervention in the percent-
age of correct answers on 4 out of the 5 items measuring CRC screening
knowledge. Speciﬁcally, there was a signiﬁcant increase regarding the
question, “CRC incidence and mortality rates are higher in Ohio
Note: Curves estimated using shared gamma frailty models fit separately to the intervention and 
comparison (usual care) data (n=522).  Curves assume mean frailty value (frailty = 1). Also 
depicted in the figure are timeframes over which the different patient-level intervention steps 
were received; the lines represent the range of times at which patients received that portion of the 
intervention and the “*”represents the median.
Fig. 2. Cumulative proportion of participants screened within guidelines during the study.
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at pre-intervention to 94.9% post-intervention (p b .0001).
Process evaluation
Clinic and provider-level
Project staff conducted monthly checks of the intervention clinics to
ensure the educational materials and posters were displayed and to re-
plenish them if needed. At the beginning of the study, 83 posters and
405 brochures were provided to the 5 intervention clinics. All posters
were displayed for the entire project duration.
All eligible physicians attended the educational session at their
respective clinic. Only two of the 39 physicians left in the middle of
the session and one did not complete the post-survey after the session.
Patient-level
At the beginning of the patient-level intervention, 63 participants
were found to be within screening guidelines. Of the remaining 217
participants, 206 (94.9%) completed step 1 of the patient-level interven-
tion. Of the 207 participants not within guidelines at the beginning of
step 2, 136 (65.7%) received the step 2 intervention. Of the 176 partici-
pants not within guidelines at the beginning of step 3 and who did not
report being within guidelines at step 2, 71 (40.3%) received the step 3
intervention (Fig. 1).
Of the 108 (38.5%) participants from the intervention clinicswho re-
ported seeing posters about CRC screening, 75 (69.4%) reported seeing
the posters in the clinic. Of the 174 (62.1%) participants from the inter-
vention clinics who reported seeing the brochures about CRC screening,
126 (72.4%) reported seeing the brochures in the clinic.
Discussion
This group randomized trial sought to assess the impact of a multi-
level (clinic, provider, patient) intervention to increase CRC screeningamong average at-risk patient participants. The ﬁndings indicate that
the intervention did not have an effect on increasing CRC screening
among participants in the intervention clinics compared to participants
in the control clinics. These results are similar to previous research that
found no signiﬁcant difference in CRC screening rates after patient, phy-
sician, and/or clinic-level interventions (Ganz et al., 2005; Jerant et al.,
2014; Ling et al., 2009). Predictors of CRC screening among participants
were full-time employment, having a FOBT in the past, being a non-
smoker, and thinking about talking to one's doctor about testing were
also consistent with previous studies (Ait Ouakrim et al., 2012;
Klabunde et al., 2005; Meissner et al., 2006; Seeff et al., 2004).
We considered a number of possible explanations for the null re-
sults, including low participation of participants in the stepped inter-
vention, as the participation rate dropped from 94.9% of eligible
participants at step 1 to 40.3% of eligible participants at step 3. Also, al-
though the intervention participants reported exposure to the clinic in-
tervention (i.e., 62.1% reported seeing the brochures), CRC screening
rates did not differ between the two study arms suggesting that the ed-
ucational materials did not motivate participants to get screened. More
research is needed to identify the proper ways to motivate average
at-risk patients to increase CRC screening.
Participants may not have been exposed to the clinic intervention as
we found that a large proportion changed their source of healthcare. In
the exit survey, approximately 47% of the intervention participants ver-
sus 38% of control clinic participants reported they were no longer a pa-
tient at the same clinic and more than 67% of intervention participants
reported not seeing the posters in the clinics. These results suggest
that the patient-oriented aspects of the clinic-level intervention may
not have been as effective as designed.
Previous studies have found that the receipt of a recommendation
for CRC screening from one's healthcare provider is the most important
predictor of participation (Ling et al., 2009;Wee et al., 2005). This study
found that thinking about talking to a doctor about completing a CRC
test was a signiﬁcant predictor of CRC screening, which coincides with
previous research. While the majority of participants did report that
Table 2
Characteristics associated with being within CRC screening guidelines by medical record review.
Predictor Level Test not
received n(%)
Test
received n(%)
OR (95% CI) p
Age (mean ± SD) 1-year increase 56.6 ± 7.2 55.3 ± 5.6 0.97 (0.94, 1.00) 0.04
Gender Female 202 (65.6) 106 (34.4) 0.92 (0.64, 1.32) 0.64
Male 140 (63.6) 80 (36.4) 1.00 (referent)
Race Black 105 (69.1) 47 (30.9) 0.82 (0.54, 1.24) 0.03
Other 13 (43.3) 17 (56.7) 2.40 (1.13, 5.12)
White 222 (64.7) 121 (35.3) 1.00 (referent)
Marital status Divorced/Separated/Widowed 132 (73.3) 48 (26.7) 0.50 (0.33, 0.75) 0.003
Single/Never married 64 (68.1) 30 (31.9) 0.64 (0.39, 1.06)
Married/Living as married 146 (57.7) 107 (42.3) 1.00 (referent)
Education Some college/associate's degree 145 (69.7) 63 (30.3) 0.94 (0.57, 1.55) 0.04
College graduate 121 (58.5) 86 (41.5) 1.54 (0.95, 2.51)
High school or less 76 (68.5) 35 (31.5) 1.00 (referent)
Employment Status Retired/volunteer 57 (67.9) 27 (32.1) 0.68 (0.41, 1.13) b0.001
Disabled/unemployed 101 (77.7) 29 (22.3) 0.41 (0.26, 0.66)
Full/part time 184 (58.8) 129 (41.2) 1.00 (referent)
Annual Income $30,000–$69,000 102 (61.8) 63 (38.2) 1.69 (1.07, 2.66) 0.003
≥$70,000 85 (55.6) 68 (44.4) 2.19 (1.38, 3.46)
b$30,000 134 (73.2) 49 (26.8) 1.00 (referent)
Insurance Public 103 (78.6) 28 (21.4) 0.82 (0.42, 1.59) b0.0001
Private 176 (56.6) 135 (43.4) 2.30 (1.31, 4.06)
Uninsured 57 (75.0) 19 (25.0) 1.00 (referent)
Smoking status Current 116 (74.8) 39 (25.2) 0.44 (0.28, 0.69) 0.001
Former 92 (67.6) 44 (32.4) 0.63 (0.40, 0.97)
Never 132 (56.7) 101 (43.3) 1.00 (referent)
Have any chronic medical conditions Yes 219 (68.2) 102 (31.8) 0.66 (0.46, 0.96) 0.03
No 118 (58.7) 83 (41.3) 1.00 (referent)
Had any tests to check for colon cancer Yes 264 (63.6) 151 (36.4) 1.26 (0.78, 2.05) 0.34
No 64 (68.8) 29 (31.2) 1.00 (referent)
Heard of and completed a FOBT Yes 42 (51.9) 39 (48.1) 1.90 (1.17, 3.06) 0.009
No 300 (67.1) 147 (32.9) 1.00 (referent)
Heard of and completed a ﬂexible sigmoidoscopy Yes 26 (59.1) 18 (40.9) 1.30 (0.69, 2.45) 0.41
No 316 (65.3) 168 (34.7) 1.00 (referent)
Heard of and completed a colonoscopy Yes 15 (62.5) 9 (37.5) 1.11 (0.48, 2.60) 0.80
No 327 (65.0) 176 (35.0) 1.00 (referent)
Indicated 50 as age for CRC screening to begin Yes 202 (60.1) 134 (39.9) 1.79 (1.21, 2.63) 0.003
No 140 (72.9) 52 (27.1) 1.00 (referent)
Willing to have a CRC screening test if it were recommended by your doctor Yes 250 (61.4) 157 (38.6) 2.02 (1.26, 3.23) 0.004
No/don't know 90 (76.3) 28 (23.7) 1.00 (referent)
Thought about talking to your doc about completing a CRC in next 6 months Yes 109 (52.4) 99 (47.6) 2.45 (1.69, 3.54) b .0001
No/don't know 232 (73.0) 86 (27.0) 1.00 (referent)
Intending to complete a CRC screening test in the next 6 months Yes 115 (59.0) 80 (41.0) 1.49 (1.03, 2.15) 0.03
No/don't know 225 (68.2) 105 (31.8) 1.00 (referent)
CRC knowledge score (mean ± SD) 1-unit increase 7.1 ± 2.1 7.5 ± 1.7 1.13 (1.02, 1.25) 0.015
CRC screening beliefs score (mean ± SD) 1-unit increase 17.4 ± 2.9 18.5 ± 2.7 1.14 (1.07, 1.22) 0.0001
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is needed as to why this did not increase CRC screening. Encouraging
physicians to address patient concerns (e.g., access, emotional barriers)
about CRC screening and offer different types of screening tests may
help increase CRC screening rates.Table 3
Multivariate logistic regression model for being within CRC screening guidelines by
medical record review, n = 483.
Predictor Level OR (95% CI) p
CRC screening belief scale
(5-item, higher = more
positive)
1-unit increase 1.11 (1.04, 1.20) 0.003
Employment Disabled/unemployed 0.49 (0.29, 0.82) 0.02
Retired/volunteer 0.72 (0.41, 1.27)
Full/part time 1.00 (referent)
Heard of and completed an
FOBT
Yes 1.90 (1.10, 3.28) 0.02
No 1.00 (referent)
Smoking status Current 0.47 (0.29, 0.78) 0.006
Former 0.58 (0.36, 0.95)
Never 1.00 (referent)
Thought about talking to
your doctor about
completing a CRC test in
next 6 months
Yes 2.33 (1.55, 3.48) b0.0001
No/don't know 1.00 (referent)Limitations
The current study had several limitations. First, the overall CRC screen-
ing rates in the clinics during the study were not measured. This would
haveprovidedmore informationabout thepotential for changingphysician
behavior and increasing rates of patient CRC screening. In addition, no en-
vironmental audits were conducted at control sites nor were physicians
compared regarding their actual screeningbehaviors. It is unknownwheth-
er control sites had similar posters and brochures available. Also, some of
the participants from the intervention clinics did not receive all of the
patient-directed stepped interventions in the proper order. For example,
14 participants were exposed to steps 1 (letter) and 3 (in-person visit),
but not step 2 (phone call). The time interval between recruitment and pa-
tient interventions may not have been ideal which suggests that future
studies could compare this sequential approach to delivering an interven-
tion with a more integrated (and shorter timeframe) approach. Lastly, the
results may have limited generalizability because participants lived in one
region of the U.S. and were primarily non-Hispanic white.Conclusion
This study tested the effectiveness of a CRC screening intervention
directed at three levels (clinic, provider, patient) in a primary care
313J.L. Krok-Schoen et al. / Preventive Medicine Reports 2 (2015) 306–313setting. The stepped patient-level intervention included a letter from
a physician and a call and in-person visit from LHAs to promote CRC
screening. The results found that there was no difference in CRC
screening rates among participants from the intervention clinics versus
control clinics, and no signiﬁcant increase in intention to screen in
the intervention participants from baseline to exit. Future studies
examining how motivation, health-behaviors, and type of supportive
environments would enhance participation in CRC screening programs
are needed.
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